FindTrial
Sign In

Comparison of the clinical outcomes for normalovulatory patients undergoing IVF procedure using mid-late follicular phase stimulation vs. Utrogestan protocol

Comparison of the clinical outcomes for normalovulatory patients undergoing IVF procedure using mid-late follicular phase stimulation vs. Utrogestan protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009349
Enrollment
Unknown
Registered
2016-10-08
Start date
2016-10-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

mid-late follicular started group:HMG
Utrogestan group:Utrogestan and HMG

Sponsors

Shanghai Ninth Peoples Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: infertility women, aged 20-40 years, normal mentrual cycle(23-35 days), tubal or male factors, basal FSH<10IU/L, antral follicle counts more than 4.

Exclusion criteria

Exclusion criteria: PCOS, endometrosis grade 3 or higher, documented ovarian failure, and any contraindications to ovarian stimulation treatment.

Design outcomes

Primary

MeasureTime frame
the number of oocytes retrieved;fertilization rate;Utilization rate of oocytes;the number of viable embryos;the pregnant rate;the implantation rate;—

Countries

China

Contacts

Public ContactYonglun Fu

Shanghai Nineth Peoples Hospital

fuyonglunivf@163.com+86 13917547302

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026